CymitQuimica logo

Tafenoquine succinate

Ref. 3D-FT178686

10mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Tafenoquine succinate
Biosynth

    Product Information

    Name:Tafenoquine succinate
    Synonyms:
    • ,,,,
    Brand:Biosynth
    Description:Tafenoquine succinate is a drug that inhibits the polymerase chain reaction, which is an enzyme activity that replicates DNA. It is also used to treat malaria and leishmaniasis. Tafenoquine succinate belongs to the class of drugs called quinoline antimalarials. It has been shown to be safe in humans, with no serious side effects. Tafenoquine succinate binds to the mitochondrial membrane potential, which prevents the accumulation of proton gradients across the inner mitochondrial membrane. This leads to an increase in intracellular calcium levels, which can cause cell death due to oxidative stress. Tafenoquine succinate also inhibits nuclear DNA replication and bacterial growth by preventing the transcription of rRNA, leading to inhibition of protein synthesis and cell division.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:581.6 g/mol
    Formula:C28H34F3N3O7
    Purity:Min. 95%
    InChI:InChI=1S/C24H28F3N3O3.C4H6O4/c1-14-11-20(32-4)30-22-18(29-15(2)7-6-10-28)13-19(31-3)23(21(14)22)33-17-9-5-8-16(12-17)24(25,26)27;5-3(6)1-2-4(7)8/h5,8-9,11-13,15,29H,6-7,10,28H2,1-4H3;1-2H2,(H,5,6)(H,7,8)
    InChI key:InChIKey=CQBKFGJRAOXYIP-UHFFFAOYSA-N
    SMILES:COc1cc(C)c2c(Oc3cccc(C(F)(F)F)c3)c(OC)cc(NC(C)CCCN)c2n1.O=C(O)CCC(=O)O

    Inquiry about discontinued product: Tafenoquine succinate

    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.